<ѻý>Trials Back Shorter DAPT After Stentingѻý> Dropping aspirin after a few weeks found non-inferior to standard yearlong regimen Mar 19, 2019
<ѻý>Non-STEMI Cardiac Arrest May Not Require Immediate Cathѻý> COACT trial not favorable on immediate coronary angiography Mar 18, 2019
<ѻý>Prescription Fish Oil Goes Beyond Preventing First CV Eventsѻý> New REDUCE-IT data point to secondary prevention benefit Mar 18, 2019
<ѻý>Bicuspid Anatomy Not Necessarily a Disadvantage for TAVRѻý> Do these registry findings warrant a randomized trial? Mar 18, 2019
<ѻý>HeartMate 3: 'A Much More Forgiving Pump'ѻý> Final data from MOMENTUM 3 still shine for safety Mar 18, 2019
<ѻý>Trial Sheds Light on Oral vs IV Antibiotics for Left-sided Endocarditisѻý> But researchers caution that more research is needed before changing practice Mar 18, 2019
<ѻý>CV Primary Prevention Guidelines Updatedѻý> Aspirin, diabetes, team-care recommendations revised Mar 17, 2019
<ѻý>Ticagrelor Antidote Clears Phase I Trialѻý> Quick reversal of P2Y12 inhibitor possible in healthy participants Mar 17, 2019
<ѻý>Glowing Reviews for Low-Risk TAVR Trials at ACCѻý> But is TAVR really the right procedure for every AS patient going forward? Mar 17, 2019
<ѻý>FDA Says Use Paclitaxel PAD Device Alternativesѻý> Interventional cardiologists weigh in Mar 17, 2019
<ѻý>Antibacterial Envelope Cuts Heart Device Infectionsѻý> Adjunctive use resulted in 40% lower incidence of major cardiac implantable electronic devices infection versus only standard care Mar 17, 2019
<ѻý>MitraClip Better for Secondary MR Quality of Lifeѻý> COAPT analysis affirms advantage over meds alone Mar 17, 2019
<ѻý>Apple Watch Pulse Warnings Fairly Accurateѻý> But Apple Heart Study authors, and other experts, say more research needed Mar 16, 2019
<ѻý>Low-Risk TAVR at Least as Good as Surgery in Pivotal Trialsѻý> Evolut, PARTNER 3 trials called "game changers" Mar 16, 2019
<ѻý>Low-Risk TAVR in Spotlight at ACCѻý> Prevention guidelines, Apple Watch also on parade in New Orleans Mar 14, 2019
<ѻý>ACC News in Brief: Weed, Flu Shots, Siestasѻý> A taste of news to come from the conference Mar 07, 2019
<ѻý>Novel Drug Reverses Anticoagulation in Emergenciesѻý> Andexanet stops 90% of action of factor Xa inhibitors Mar 13, 2018
<ѻý>Barbershops Trim Blood Pressure among Blacksѻý> One-stop shopping for haircut and hypertension treatment Mar 13, 2018
<ѻý>Low-Dose Combo Pill Successfully Takes Down High BPѻý> Fixed dose initial treatment gets 70% of patients at hypertension goal Mar 13, 2018
<ѻý>Mixed Results for Shorter DAPT in ACS Patientsѻý> Shorter regimen non-inferior to standard care, but not ready for prime-time Mar 13, 2018
<ѻý>Gene Therapy Flops for Critical Limb Ischemiaѻý> Non-viral biologic agent didn't improve wound healing Mar 12, 2018
<ѻý>Gout Drug Raises Safety Concerns With Death Excess in Trialѻý> Febuxostat linked especially to sudden cardiac deaths in CARES trial Mar 12, 2018
<ѻý>Perioperative Beta Blockers Trade Fewer MIs for More Deathsѻý> Issue of safety highlighted again in POISE analysis Mar 12, 2018
<ѻý>P2Y12 Tx Subsidy Yields Positive Response from Docs, Patientsѻý> Ticagrelor vouchers boost use, but clinical outcomes unchanged Mar 11, 2018
<ѻý>Newer HeartMate LVAD Better for Longer-Term Useѻý> 2-year MOMENTUM 3 results set a 'new standard for pump failure' Mar 11, 2018
<ѻý>NOAC Helps Stem Consequences of Cardiac Damage After Surgeryѻý> Fewer major vascular events with therapy after myocardial injury Mar 11, 2018
<ѻý>Inhaled Nitrite Flops as HFpEF Therapyѻý> Optimal duration and mode of delivery remain open questions Mar 11, 2018
<ѻý>Ticagrelor Can Safely Follow Lytic Tx for STEMIѻý> Bleeding similar upon delayed adminstration of ticagrelor versus clopidogrel Mar 11, 2018
<ѻý>Praluent Price to Drop for Insurers That Ease Rx Restrictionsѻý> Sanofi/Regeneron announced plan to bring PCSK9 drug within cost-effective range Mar 10, 2018
<ѻý>Mixed Results with LifeVest for Post-MI Preventionѻý> No reduction in sudden deaths, but benefit in secondary outcomes with external defibrillator Mar 10, 2018
<ѻý>Praluent Delivers CV Event Prevention in ODYSSEYѻý> Second PCSK9 outcomes trial comes out like FOURIER -- but with mortality reduction Mar 10, 2018
<ѻý>Open Mic at ACC: Tribal Diet; 'Jeopardy!'; How to Retireѻý> In this video, cardiologists share favorite moments from the meeting Apr 06, 2017
<ѻý>ACC: Another HDL Therapy Crashes and Burnsѻý> Failure of pre-beta HDL mimetic puts another nail in the HDL coffin Mar 19, 2017
<ѻý>ACC: FOURIER Substudy May Help Refute 'Dr. Google'ѻý> No neurocognitive adverse effects linked to very low LDL levels Mar 19, 2017
<ѻý>ACC: Novel Drug Fails to Reduce Post-Op Risksѻý> A calcium sensitizer flops in study aimed at cutting post-op risks Mar 19, 2017
<ѻý>ACC: Medicine Needs Art to Flourishѻý> "Science is not enough to solve the world's thorniest problems" Mar 18, 2017
<ѻý>ACC: Medical Tx Comparable to Stenting for CTOsѻý> Intention-to-treat analysis of DECISION-CTO trial Mar 18, 2017
<ѻý>ACC: Online Videos Help HTN Adherenceѻý> Blood pressure, Framingham risk improved in small trial Mar 18, 2017
<ѻý>ACC: Novel Drug Delivers Long-Term Cholesterol Reductionѻý> RNA interference drug inhibits synthesis of PCSK9 Mar 18, 2017
<ѻý>ACC: Even Very Low Dose Rivaroxaban Prevents Recurrent VTEѻý> Results from EINSTEIN CHOICE point to new clinical pathway Mar 18, 2017